Rassegna stampa
Dermatologia13 nov 2017
Secukinumab Reduces Anxiety, Depression in Patients With Psoriatic Arthritis
The higher anxiety and depression burden typically seen in patients with psoriatic arthritis and psoriasis is improved with secukinumab treatment
08 nov 2017
I farmaci biologici sono efficaci contro la psoriasi anche per anni
Un'indagine svedese ha seguito i pazienti per anni, analizzando l'efficacia dei medicinali e la qualità di vita delle persone. Le conclusioni: Funzionano e sono ben tollerati
03 nov 2017
Cassazione: il rispetto delle linee guida cancella tutti i casi di colpa medica
La legge Gelli-Bianco del marzo 2017 ha introdotto una causa di non punibilità del medico che, a determinate condizioni, scatta indipendentemente dal grado della colpa.
31 ott 2017
Timing of Melanoma Diagnosis, Treatment Critical to Survival
A study published in the Journal of the American Academy of Dermatology (JAAD) underscores the importance of early detection and treatment of melanoma
31 ott 2017
Study Defines Safe, Effective Margins for Complete Removal of Individual Dysplastic Nevi
By carefully tracing a line of at least 2 mm outside of and around the edges of individual dysplastic nevi, physicians can remove all of its cells and avert the need for a second surgery
24 ott 2017
I tatuaggi possono provocare infezioni a distanza di anni
Una donna di 30 anni si è presentata in ospedale con dei rigonfiamenti. Si era tatuata 15 anni prima.
24 ott 2017
Psoriasi per due milioni di italiani. Malattia troppo spesso trascurata
Con una diagnosi precoce e le terapie adeguate si può evitare che peggiori, ma troppi pazienti non si curano. Il 28 e 29 ottobre gazebo per visite e controlli gratuiti
24 ott 2017
Apremilast Demonstrates Improves Scalp and Nail Psoriasis in Patients With Moderate Plaque Psoriasis
Psoriasis occurring on the scalp and nail are difficult-to-treat manifestations of plaque psoriasis that often are disproportionately more distressing to patients than on other areas
24 ott 2017
Patients Highly Satisfied With Apremilast Results in Treatment of Moderate Plaque Psoriasis
Patients receiving apremilast for moderate plaque psoriasis reported improved quality of life and high satisfaction with the treatment
24 ott 2017
Brodalumab Achieves Superior Lesion Clearance Compared With Secukinumab and Ustekinumab in Moderate-to-Severe Psoriasis
More patients with moderate-to-severe psoriasis achieved "clear" or "almost clear" status with brodalumab than with secukinumab using Psoriasis Area and Severity (PASI) scores
10 ott 2017
Psoriasi e alcol, un legame mortale
I pazienti psoriasici hanno circa il 60% in più di probabilità, rispetto a soggetti della stessa età e sesso, di morire per patologie causate dall'eccessivo consumo di alcolici
10 ott 2017
Brodalumab Shows Sustained Efficacy in Treating Moderate-to-Severe Psoriasis
Brodalumab achieved high levels of lesion clearance in the majority of patients with moderate-to-severe psoriasis, with results sustained through 120 weeks
10 ott 2017
Switching to Brodalumab From Ustekinumab Improves Clearance in Moderate-to-Severe Psoriasis
Patients with moderate-to-severe psoriasis that did not adequately respond to ustekinumab achieve high levels of lesion clearance after switching to brodalumab rescue therapy
10 ott 2017
Pruritus Symptoms Reduced With Apremilast in Patients With Chronic Plaque Psoriasis
Apremilast was effective in reducing the symptoms of pruritis and improving quality of life in patients with chronic plaque psoriasis attending a university clinic
02 ott 2017
Crisaborole Ointment Resolves Atopic Dermatitis Lesions, Regardless of Ethnicity
Topically applied crisaborole ointment was more effective than placebo vehicle for the treatment of mild-to-moderate atopic dermatitis across racial and ethnic groups, with more patients achieving “clear” or “almost clear” status
02 ott 2017
Omeprazole Plus Erythromycin an Alternative to Doxycycline in Acne Vulgaris
Oral omeprazole plus erythromycin 4% was more effective than doxycycline plus erythromycin 4% combination therapy in resolving non-inflammatory acne vulgaris skin lesions, and caused fewer non-skin related side effects
02 ott 2017
Tofacitinib Improves Plaque-Psoriasis Symptoms in Psoriatic Arthritis
Patients with active psoriatic arthritis and plaque psoriasis showed resolution of skin lesions within 3 weeks, as indicated by achieving Psoriasis Area and Severity Index (PASI 75) and PASI 90 with tofacitinib
02 ott 2017
Infliximab Biosimilar Safe and Effective in Infliximab-Naïve Patients With Plaque Psoriasis or Psoriatic Arthritis
Patients with plaque psoriasis, psoriatic arthritis, or both showed had a strong response to biosimilar infliximab (CT-P13)
19 set 2017
Adjuvant Vemurafenib Benefits Patients With Resected, BRAFV600-Positive Melanoma
Adjuvant vemurafenib provides significantly improved disease-free survival (DFS) and distant metastasis-free survival (DMFS) compared with placebo in patients positive for the BRAFV600 mutation with completely resected stage IIC to IIIB melanoma who are at high recurrence risk, according to findings from the BRIM8 study, presented at the 42nd European Society for Medical Oncology (ESMO) Congress
19 set 2017
Nivolumab Superior To Ipilimumab as Adjuvant Therapy in Resected, Late-Stage Melanoma
Nivolumab demonstrates greater clinical benefit and superior safety compared with ipilimumab in patients with completely resected late-stage melanoma at high risk of recurrence